Verrica Pharmaceuticals VRCA

$ 0.7 3.52%

Quarterly report 2024-Q2
added 08-14-2024

Verrica Pharmaceuticals Income Statement 2011-2024 | VRCA

Annual Income Statement Verrica Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	245 M	252 M	227 M	294 M	363 M	176 M	-	-	-	-	-	-	-
Shares	45.3 M	34.2 M	27 M	25 M	24.9 M	14.7 M	-	-	-	-	-	-	-
Historical Prices	5.41	7.39	8.38	13.7	11.9	11.3	-	-	-	-	-	-	-
Net Income	-67 M	-24.5 M	-35.1 M	-42.7 M	-28.2 M	-20.6 M	-4.46 M	-1.91 M	-	-	-	-	-
Revenue	5.12 M	9.03 M	12 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	500 K	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-65.8 M	-21.3 M	-30.9 M	-40.2 M	-30.1 M	-21.9 M	-4.46 M	-	-	-	-	-	-
Interest Expense	3.96 M	2.17 M	4.3 M	3.03 M	-	-	-	-	-	-	-	-	-
EBITDA	-65.2 M	-20.8 M	-30.7 M	-40 M	-29.8 M	-21.9 M	-4.46 M	-1.91 M	-	-	-	-	-
Operating Expenses	70.9 M	30.3 M	42.9 M	40.2 M	30.1 M	21.9 M	-	-	-	-	-	-	-
General and Administrative Expenses	47.3 M	17.4 M	27 M	24.5 M	14.6 M	9.05 M	727 K	204 K	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Verrica Pharmaceuticals

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	46.5 M	46.5 M	42.4 M	46.1 M	45.9 M	43 M	41.1 M	40.3 M	27.5 M	27.5 M	27.5 M	27.5 M	27.5 M	25.6 M	25.4 M	25 M	25 M	25 M	24.9 M	24.9 M	24.9 M	24.9 M	24.8 M	24.8 M	5.75 M	2.85 M	2.85 M	2.85 M	2.85 M	2.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-17.2 M	-20.3 M	-	-24.8 M	-11 M	-6.59 M	-	83 K	-10.2 M	-8.47 M	-	-12.8 M	-11.8 M	-936 K	-	-10.5 M	-9.41 M	-9.82 M	-7.64 M	-6.09 M	-7 M	-7.48 M	-7.58 M	-5.91 M	-5.32 M	-1.85 M	-1.44 M	-1.36 M	-1.1 M	-570 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	5.18 M	3.83 M	-	2.92 M	182 K	37 K	-	8.32 M	214 K	431 K	-	-	-	12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	700 K	700 K	-	300 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-15.2 M	-18.6 M	-	-23.9 M	-11.6 M	-7.09 M	-	1.45 M	-9.12 M	-7.41 M	-	-11.8 M	-10.7 M	60 K	-	-9.64 M	-8.63 M	-9.88 M	-7.99 M	-6.54 M	-7.52 M	-8.03 M	-8.19 M	-6.33 M	-5.47 M	-1.89 M	-1.43 M	-1.36 M	-1.1 M	-570 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.37 M	2.32 M	-	1.66 M	-	-	-	81 K	1.07 M	1.08 M	-	1.09 M	1.08 M	1.03 M	-	918 K	904 K	220 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-15.1 M	-18.5 M	-	-	-11.5 M	-6.96 M	-	1.77 M	-8.92 M	-7.31 M	-	-11.7 M	-10.7 M	71 K	-	-9.61 M	-8.6 M	-9.87 M	-7.99 M	-6.5 M	-7.5 M	-8.02 M	-8.19 M	-6.32 M	-5.46 M	-1.89 M	-1.43 M	-1.36 M	-1.1 M	-570 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	20.4 M	22.4 M	-	26.8 M	11.8 M	7.13 M	-	6.87 M	9.34 M	7.84 M	-	11.8 M	10.7 M	11.9 M	-	9.64 M	8.63 M	9.88 M	7.99 M	6.54 M	7.52 M	8.03 M	8.19 M	6.33 M	5.47 M	1.89 M	1.43 M	1.36 M	1.1 M	570 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	16.5 M	16.3 M	-	20.1 M	5.94 M	4.32 M	-	3.92 M	5.17 M	5.12 M	-	8 M	7.28 M	6.58 M	-	4.65 M	5.11 M	4.99 M	4.02 M	3.49 M	3.59 M	3.54 M	3.27 M	2.86 M	1.96 M	961 K	316 K	238 K	118 K	55 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency